Millennium Special Lab Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.45 M
- Company Age 24 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 2.62 Cr
- Satisfied Charges ₹ 4.55 M
- Revenue Growth -15.08%
- Profit Growth -80.76%
- Ebitda -55.41%
- Net Worth 6.46%
- Total Assets -21.34%
About Millennium Special Lab
Millennium Special Lab Private Limited (MSLPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 17 August 2000 and has a history of 24 years and six months. Its registered office is in Thane, Maharashtra, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.45 M.
The company currently has active open charges totaling ₹2.62 Cr. The company has closed loans amounting to ₹4.55 M, as per Ministry of Corporate Affairs (MCA) records.
Swati Vaidya, Ulhas Vaidya, Rohit Kulkarni, and One other member serve as directors at the Company.
Company Details
- Location
Thane, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U85195MH2000PTC128307
- Company No.
128307
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
17 Aug 2000
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Millennium Special Lab?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ulhas Vaidya  | Managing Director | 17-Aug-2000 | Current |
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Swati Vaidya | Director | 17-Aug-2000 | Current |
| Rohit Kulkarni | Director | 11-Oct-2022 | Current |
| Omkar Vaidya | Director | 28-May-2019 | Current |
Financial Performance of Millennium Special Lab.
Millennium Special Lab Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 15.08% decrease. The company also saw a substantial fall in profitability, with a 80.76% decrease in profit. The company's net worth moved up by a moderate rise of 6.46%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Millennium Special Lab?
Unlock access to Millennium Special Lab's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Reelabs Private LimitedRohit Kulkarni is a mutual person
Ocean View Kihim LlpSwati Vaidya and Ulhas Vaidya are mutual person
- Satiava Healthcare Llp
Rohit Kulkarni is a mutual person
- R K Ubiquitous Strategic Advisors And Consultants Llp
Rohit Kulkarni is a mutual person
- Ibhaan Pharmaceuticals Private Limited
Rohit Kulkarni is a mutual person
Charges (Loans)
₹26.20 M
₹4.55 M
Charges Breakdown by Lending Institutions
- Others : 2.62 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 22 Mar 2024 | Others | ₹1.20 M | Open |
| 27 Jan 2023 | Others | ₹2.50 Cr | Open |
| 31 Mar 2022 | Others | ₹1.50 M | Satisfied |
| 03 Dec 2020 | Others | ₹0.58 M | Satisfied |
| 27 Nov 2020 | Others | ₹0.58 M | Satisfied |
How Many Employees Work at Millennium Special Lab?
Unlock and access historical data on people associated with Millennium Special Lab, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Millennium Special Lab, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Millennium Special Lab's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.